Home ›
Trademark Categories ›
Pharmaceuticals ›
2019 ›
VY ›
VYSPREE
Trademark search for:
VYSPREE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-12-17 — Application filed
2019-12-20 — Application filed
2019-12-20 — Application filed
2020-03-13 — Assigned to examiner
2020-03-16 — Final disposition recorded
2020-03-16 — Final disposition recorded
2020-03-16 — Final disposition recorded
2020-04-09 — Office action issued
2020-04-16 — Assigned to lie
2020-04-17 — Teas/email correspondence entered
2020-04-17 — Correspondence received in law office
2020-05-06 — Approved for pub - principal register
2020-05-27 — Notification of notice of publication e-mailed
2020-06-16 — Published for opposition
2020-06-16 — Official gazette publication confirmation e-mailed
2020-08-11 — Noa e-mailed - sou required from applicant
2021-02-03 — Sou teas extension received
2021-02-03 — Sou extension 1 filed
2021-02-03 — Sou extension 1 granted
2021-02-05 — Notice of approval of extension request e-mailed
2021-07-30 — Sou teas extension received
2021-07-30 — Sou extension 2 filed
2021-07-30 — Sou extension 2 granted
2021-08-03 — Notice of approval of extension request e-mailed
2022-02-11 — Sou teas extension received
2022-02-11 — Sou extension 3 filed
2022-02-11 — Sou extension 3 granted
2022-02-15 — Notice of approval of extension request e-mailed
2022-08-11 — Sou teas extension received
2022-08-11 — Sou extension 4 granted
2022-08-11 — Sou extension 4 filed
2022-08-13 — Notice of approval of extension request e-mailed
2023-02-08 — Sou teas extension received
2023-02-08 — Sou extension 5 filed
2023-02-27 — Case assigned to intent to use paralegal
2023-02-27 — Sou extension 5 granted
2023-02-28 — Notice of approval of extension request e-mailed
2023-09-11 — Application abandoned
2023-09-11 — Application abandoned
2023-09-11 — Final status recorded
Owner Information
Biomarin Pharmaceutical Inc.
Biomarin Pharmaceutical Inc.
Correspondent
Gregory J. Chinlund MARSHALL, GERSTEIN & BORUN LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
